Akèy › Maladi poumon entèstisyèl › Texas
Etid klinik pou Maladi poumon entèstisyèl nan Texas
19 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Baylor College of Medicine, Houston
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Stryde Research, Carrollton
- Baylor University Medical Center, Dallas
- Discovery Clinical Trials, San Antonio
- ak 1 plis
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Baylor University Medical Center, Dallas
- Metroplex Pulmonary & Sleep Center, McKinney
- UT Health San Antonio, San Antonio
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07540988A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
- The University of Texas Health Science Center at Houston, Houston
- University of Texas Health Science Center at San Antonio, San Antonio
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06806592A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Denison
- GSK Investigational Site, El Paso
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05878717A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Houston
- GSK Investigational Site, Temple
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06572384A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- El Paso Pulmonary Association, El Paso
- Baylor College of Medicine, Houston
- Baylor Scott and White Health, Temple
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Houston
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Baylor University Medical Center, Dallas
- Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Baylor University Medical Center, Dallas
- UT Southwest Medical Center Heart and Lung Clinic, Dallas
- Houston Methodist, Houston
- ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- University of Texas Southwestern, Dallas
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Aug 18, 2026 · NCT06855329Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
- Baylor College of Medicine, Houston
- ak 2 plis
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Houston Methodist Hospital, Houston
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Aug 10, 2026 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Baylor University Medical Center, Dallas
- UT Southwestern Medical Center-Advanced Lung Clinic, Dallas
- Houston Methodist Outpatient Center, Houston
- ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05943535TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Baylor College of Medicine/Texas Children'S Hospital, Houston
Ap rekriteEtid obsèvasyon
Jiska laj 24 · Tout sèks · Mizajou Jun 22, 2026 · NCT04098445A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
- Galderma Investigational Site#7096, Arlington
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 31, 2026 · NCT07047690Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Texas Southwestern Medical Center, Dallas
- Metroplex Pulmonary and Sleep Center, McKinney
- Research Centers of America, McKinney
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Dallas
- aTyr Investigative Site, Houston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2025 · NCT05892614Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.